This newsletter by Indy Sawhney, an AI strategy leader at AWS, offers practical advice for organizations struggling to scale Agentic AI. The text argues that many initiatives fail because teams focus on the novelty of technology rather than addressing specific business outcomes prioritized by executive leadership. Using a pharmaceutical case study, the author illustrates how to move past impressive demos by identifying operational bottlenecks where speed and scale are most critical. The source provides a framework for reverse mapping AI capabilities to the goals found in annual reports, ensuring projects secure budget and support. Ultimately, the newsletter serves as a guide for leaders to bridge the gap between experimental automation and meaningful corporate strategy.